###begin article-title 0
A unique B2 B cell subset in the intestine
###end article-title 0
###begin p 1
###xml 34 57 34 57 <email xmlns:xlink="http://www.w3.org/1999/xlink">amizoguchi@partners.org</email>
CORRESPONDENCE Atsushi Mizoguchi: amizoguchi@partners.org
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 122 123 122 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 311 312 311 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 347 348 347 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 352 353 352 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 357 358 357 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 400 406 400 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink">bright</sup>
###xml 720 721 720 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Over 80% of the body's activated B cells are located in mucosal sites, including the intestine. The intestine contains IgM+ B cells, but these cells have not been characterized phenotypically or in terms of their developmental origins. We describe a previously unidentified and unique subset of immunoglobulin M+ B cells that present with an AA4.1-CD21-CD23- major histocompatibility complex class IIbright surface phenotype and are characterized by a low frequency of somatic hypermutation and the potential ability to produce interleukin-12p70. This B cell subset resides within the normal mucosa of the large intestine and expands in response to inflammation. Some of these intestinal B cells originate from the AA4.1+ immature B2 cell pool in the steady state and are also recruited from the recirculating naive B cell pool in the context of intestinal inflammation. They develop in an antigen-independent and BAFF-dependent manner in the absence of T cell help. Expansion of these cells can be induced in the absence of the spleen and gut-associated lymphoid tissues. These results describe the existence of an alternative pathway of B cell maturation in the periphery that gives rise to a tissue-specific B cell subset.
###end p 3
###begin p 4
Abbreviations used: BAFF-R, receptor of B cell activation factor from the TNF family; Btk, Bruton's tyrosine kinase; DSS, dextran sodium sulfate; FDC, follicular dendritic cell; GALT, gut-associated lymphoid tissue; LT, lymphotoxin; MLN, mesenteric lymph node; PP, Peyer's patch; SHM, somatic hypermutation.
###end p 4
###begin p 5
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 214 215 214 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 220 221 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 723 724 723 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 726 727 726 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 729 730 729 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 828 829 828 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 917 919 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
BM-derived immature IgM+ B cells can mature in the BM itself or migrate to the spleen and mature into follicular and marginal zone B cells (1-7). Maturation proceeds through short-lived transitional B cell stages (2, 3, 8), and several specific signaling receptors and transcription factors are involved in this process (1-6). Newly formed B cells that have recently emerged from the BM represent the T1 transitional stage of development in which cells express high levels of CD24 and AA4.1 and low levels of CD23, CD21, and IgD. At the T2 stage, cells acquire the ability to recirculate and to express higher levels of CD23, CD21, and IgD, and they are capable of maturing into either marginal zone or follicular B cells (2, 5, 9). The T3 subset may represent a specific follicular B cell population that has recently matured (3), but it has also been recently suggested that T3 cells may represent anergic B cells (10).
###end p 5
###begin p 6
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 436 437 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 540 542 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
In several systemic and organ-specific inflammatory disorders, ectopic neolymphoid follicles, which are sometimes called tertiary lymphoid tissue, are induced by the mobilization of B cell progenitors from the BM to the periphery (11-15). Interestingly, although the BM functions as a primary lymphoid organ, it may also serve as a secondary lymphoid organ in which activation of B cells may occur in response to circulating pathogens (7, 16). Although >80% of the body's B cells are located in gut-associated lymphoid tissues (GALTs) (17, 18), it is unknown whether these cells are derived from the activation of recirculating B cells or if they include novel populations of naive B cells that specifically home to these sites.
###end p 6
###begin p 7
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 392 394 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 396 398 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 399 401 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 464 465 460 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 562 563 558 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 578 580 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 581 583 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 585 587 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 588 590 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 704 705 700 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 984 986 980 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 987 989 983 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 991 993 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 994 996 990 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 1031 1032 1027 1028 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1178 1180 1174 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 1181 1183 1177 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 1245 1246 1241 1242 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
The mucosal immune system is constitutively exposed to a wide spectrum of commensal microflora (18-21). The effecter lymphoid component of GALT includes scattered lymphocytes throughout the lamina propria of the small and large intestine. The inductive sites consist of organized lymphoid tissues, such as Peyer's patches (PPs), which are formed in a lymphotoxin (LT)-alpha dependent manner (17, 19-22). Because the small intestine represents a major source of IgA+ plasma cells, the majority of studies on intestinal B cells have focused on small intestinal IgA+ plasma cells (17-20, 23-28). Three pathways have been identified for small intestinal plasma cell development. Approximately half of all IgA+ plasma cells in the intestine may originate from peritoneal B1 cells, whereas the remainder may be either derived from activated B cells that migrate from organized lymphoid tissues such as PPs, or originate from naive B cells through a distinct pathway for gut-primed B cells (17-20, 23-28). In addition to plasma cells, IgM+ B cells also exist within the normal intestine and significantly increase within large intestinal mucosal tissues during inflammatory responses (29-32). However, the phenotypic and developmental properties of IgM+ B cells in the intestine have not yet been fully explored.
###end p 7
###begin p 8
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 111 112 111 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 116 117 116 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 121 122 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 127 133 127 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">bright</sup>
###xml 432 433 432 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 472 473 472 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
We describe a previously unidentified, intestine-specific, IgM+ B cell subset that is characterized by an AA4.1-CD21-CD23-MHCIIbright phenotype, by a low frequency of somatic hypermutation (SHM), and by the potential ability to produce IL-12p70 after exposure to microbes. These cells appear to exist in a unique preactivated state, as indicated by the very high expression levels of MHC class II on these cells. This intestinal IgM+ B cell subset may originate from AA4.1+ immature transitional B cells in the steady state, and may be significantly increased in the inflamed intestine after recruitment from the recirculating naive B cell pool.
###end p 8
###begin title 9
RESULTS
###end title 9
###begin title 10
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Identification of a unique AA4.1-CD21-CD23-IgM+ B cell subset in the large intestine
###end title 10
###begin p 11
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 234 235 234 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 473 474 473 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 491 492 491 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 496 497 496 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 500 503 500 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 505 513 505 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 621 623 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 624 626 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 666 667 666 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 902 904 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 906 908 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 910 912 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 943 945 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 947 949 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 981 982 977 978 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1069 1077 1061 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 1408 1409 1400 1401 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1568 1583 1560 1575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, B and C</xref>
###xml 1612 1613 1604 1605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1653 1654 1645 1646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1708 1709 1700 1701 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1713 1714 1705 1706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1717 1720 1709 1712 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 1732 1740 1724 1732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 1816 1828 1808 1820 <sup xmlns:xlink="http://www.w3.org/1999/xlink">intermediate</sup>
###xml 1833 1834 1825 1826 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1838 1839 1830 1831 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1899 1907 1891 1899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 E</xref>
###xml 2028 2036 2020 2028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 F</xref>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 751 755 <span type="species:ncbi:10090">mice</span>
###xml 803 807 <span type="species:ncbi:10090">mice</span>
###xml 1045 1049 <span type="species:ncbi:10090">mice</span>
###xml 1063 1067 <span type="species:ncbi:10090">mice</span>
IgM+ B cells have been described in the large intestine, and these cells expand significantly and form B cell clusters in certain disease states involving intestinal inflammation (29-32). We herein demonstrate that the majority of IgM+ B cells in the large intestine of WT mice exhibit a unique surface phenotype that is distinct from that of recirculating splenic and mesenteric LN (MLN) B cells. In contrast to splenic, MLN, and PP B cells, the majority of intestinal IgM+ B cells are CD21-CD23-IgDlow (Fig. 1 A). Because a significant increase in intestinal B cells has been well documented in several colitis models (29-32), we next examined the phenotype of IgM+ B cells from the inflamed intestine of three colitis models, including TCRalpha KO mice (Th2 cell-dependent chronic colitis), IL-10 KO mice (Th1 cell-dependent chronic colitis), and dextran sodium sulfate (DSS)-induced acute colitis (29, 32, 33). As previously demonstrated (29, 32), a significant increase in IgM+ B cells was observed in the inflamed intestine of TCRalpha KO mice and IL-10 KO mice (Fig. 1 B). Interestingly, we found that in the DSS colitis model intestinal B cell expansion was specifically induced during the recovery phase (after termination of DSS treatment), but not during the acute phase when DSS was being administered. In comparison to day 0 (normal mucosa), the proportion as well as the absolute numbers of IgM+ cells in the large intestine were slightly decreased at day 4 (acute phase), but increased significantly at day 8 (during the recovery phase) of DSS colitis (Fig. 1, B and C). Like normal intestinal IgM+ B cells, the majority of intestinal IgM+ B cells in these colitis models were also of the CD21-CD23-IgDlow phenotype (Fig. 1 D). In addition, intestinal B cells from normal and inflamed mucosa were CD24intermediateCD62L-CD1d+ and did not express B1 cell markers (CD43, CD11b, and CD5; Fig. 1 E and Fig. S1). The intestinal B cells proliferated in vitro in the response to BCR ligation, as well as LPS stimulation (Fig. 1 F). These findings define a previously unidentified, unique B cell subset that exists in normal and inflamed large intestine.
###end p 11
###begin p 12
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Identification of a unique IgM<sup>+</sup> B cell subset in the large intestine.</bold>
###xml 484 485 478 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 543 544 537 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 575 576 569 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 715 716 699 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 742 743 726 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 777 778 761 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1143 1144 1123 1124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1149 1150 1129 1130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1369 1370 1349 1350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1484 1485 1463 1464 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 471 475 <span type="species:ncbi:10090">mice</span>
###xml 516 520 <span type="species:ncbi:10090">mice</span>
###xml 709 713 <span type="species:ncbi:10090">mice</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
###xml 990 994 <span type="species:ncbi:10090">mice</span>
###xml 1009 1013 <span type="species:ncbi:10090">mice</span>
###xml 1616 1620 <span type="species:ncbi:10090">mice</span>
Identification of a unique IgM+ B cell subset in the large intestine. (A) Expressions of IgM versus IgD, CD21, or CD23 of the cells from colon, spleen (SP), MLN, and PP of WT mice are shown. (B) For DSS colitis, intestinal inflammation was induced by administration of 4% DSS in drinking water, and the treatment was terminated by changing DSS water to normal water at day 4. (top) Proportions of IgM versus CD3epsilon-expressing cells in the large intestine from normal mice (Day 0, n = 21) and DSS-induced colitis mice (Day 4 [acute phase], n = 11; Day 8 [recovery phase], n = 24). (bottom) Proportions of IgM versus CD3epsilon-expressing cells in the large intestine of chronic colitis models, TCRalpha KO mice (n = 3), and IL-10 KO mice (n = 3). (C) Absolute numbers of IgM+ cells in the large intestine of DSS colitis at day 0, 4, 8, and 30 are shown. (D) Expressions of IgM versus CD23, CD21, or IgD on the cells from large intestine of three colitis models (DSS colitis, TCRalpha KO mice, and IL-10 KO mice) are shown. The data are representative of 3-11 individual experiments. (E) Expression of several surface makers on the gated IgM+ B220+ cells from the large intestine of DSS at day 8 (solid lines) and from spleen (dot lines) is shown. The data are representative of 11 individual experiments. (F) Proliferative responses of purified B cells (>95% are IgM+) from the colon (shaded bars) and spleen (open bars) to stimulation without (No) or with LPS (5 mug/ml) or F(ab')2 anti-Igmu Abs (anti-mu; 50 mug/ml) are shown. The results represent the mean +/- the SEM of triplicate data from three individual mice.
###end p 12
###begin title 13
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Intestinal B cells are derived from AA4.1+ immature and transitional B cells
###end title 13
###begin p 14
###xml 485 486 485 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 490 491 490 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 968 976 968 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 991 992 991 992 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1022 1023 1022 1023 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1081 1082 1081 1082 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1099 1100 1099 1100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1110 1118 1110 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 1145 1146 1145 1146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1150 1151 1150 1151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1155 1156 1155 1156 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1215 1216 1215 1216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1302 1304 1302 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 1319 1320 1319 1320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1324 1325 1324 1325 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1385 1386 1385 1386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1391 1392 1391 1392 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1467 1475 1467 1475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 1500 1501 1500 1501 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1506 1507 1506 1507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1555 1556 1555 1556 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1559 1560 1559 1560 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1613 1621 1613 1621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 1749 1750 1749 1750 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1833 1834 1833 1834 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1861 1862 1861 1862 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1867 1868 1867 1868 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1950 1951 1950 1951 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 2026 2027 2026 2027 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2031 2032 2031 2032 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2111 2119 2111 2119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 2150 2151 2150 2151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2155 2156 2155 2156 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2204 2212 2204 2212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 2235 2236 2235 2236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2240 2241 2240 2241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2308 2316 2308 2316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 1375 1379 <span type="species:ncbi:10090">mice</span>
###xml 1900 1915 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1975 1979 <span type="species:ncbi:10090">mice</span>
###xml 2097 2102 <span type="species:ncbi:10090">mouse</span>
Intestinal B cells with their unique phenotype could either represent a naive or an activated B cell population. These cells could develop in the intestine in situ from uncommitted lymphoid progenitors, or they may be derived from newly formed B cells that not only seed the spleen but also home to the intestine, or they could represent a population that differentiates from recirculating follicular phenotype B cells or from B1 B cells. The rapid expansion of intestine-specific CD21-CD23- B cells in the DSS colitis model provided us an opportunity to more closely examine how these cells expand either by proliferation of existing cells or by enhanced recruitment or development from progenitors. Because intestinal B cells share some phenotypic features with T1 B cells, but the latter also express AA4.1, a marker for recently generated B cells, (34), we next examined AA4.1 expression on intestinal B cells. Less than 10% of intestinal B cells expressed AA4.1 (Fig. 2 A). Unlike AA4.1- intestinal B cells, the AA4.1+ intestinal B cells consisted of two subsets, T1-like CD23- and T2-like CD23+ B cells (Fig. 2 A). To examine whether AA4.1-CD21-CD23- intestinal B cells could potentially mature from the AA4.1+ immature B cells, in vivo BrdU pulse labeling was performed as previously described (35). In the AA4.1+ IgM+ population from the normal large intestine of WT mice, BrdU+ B220+ cells were observed on both day 2 and 6 after the initial BrdU injection (Fig. 2 B, top). In contrast, BrdU+ B220+ cells were not detectable at day 2 in the AA4.1-IgM+ population, but became clearly detectable at day 6 (Fig. 2 B, bottom). Similar findings were also observed in the inflamed intestine after DSS treatment (Fig. S2). To confirm whether AA4.1+ immature B cells actually possess the ability to differentiate into intestinal IgM+ B cells, we purified AA4.1+ B220+ B cells from the spleen of GFP transgenic mice, and then transferred them (5 x 106) intravenously into WT mice, with or without induction of DSS colitis. GFP+ IgM+ B cells were detected in the colon and spleen of both recipient mouse groups (Fig. 2 C, right). The reconstituted GFP+ IgM+ B cells in the spleen expressed CD21 and CD23 (Fig. 2 D). In contrast, the GFP+ IgM+ B cells reconstituted in the colon did not express CD21 and CD23 (Fig. 2 D).
###end p 14
###begin p 15
###xml 26 27 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 53 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Direct maturation of AA4.1<sup>+</sup> immature B cells to AA4.1</bold>
###xml 53 54 53 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 54 73 54 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">intestinal B cells.</bold>
###xml 383 384 383 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 389 390 389 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 406 407 406 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 661 662 661 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 677 678 677 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 691 692 691 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 816 817 816 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 822 823 822 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1161 1162 1161 1162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1343 1347 1343 1347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 1700 1701 1700 1701 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 550 554 <span type="species:ncbi:10090">mice</span>
###xml 855 870 <span type="species:ncbi:10090">transgenic mice</span>
###xml 917 921 <span type="species:ncbi:10090">mice</span>
###xml 997 1001 <span type="species:ncbi:10090">mice</span>
###xml 1206 1210 <span type="species:ncbi:10090">mice</span>
###xml 1379 1394 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1434 1438 <span type="species:ncbi:10090">mice</span>
###xml 1537 1541 <span type="species:ncbi:10090">mice</span>
###xml 1774 1778 <span type="species:ncbi:10090">mice</span>
Direct maturation of AA4.1+ immature B cells to AA4.1-intestinal B cells. (A) Intestinal inflammation was induced by administration of 4% DSS in drinking water and the treatment was terminated by changing the DSS-containing water to normal water at day 4. Expression of AA4.1 versus B220 (top) in total large intestinal cells (day 8) and CD23 versus IgM expression on the gated AA4.1+ B220+ cells (bottom; n = 12) is shown. (B) 1 mg BrdU was administered (intraperitoneally) into intact WT mice twice with a 24-h interval between injections, and the mice were killed at 2 and 6 d after initial BrdU injection. The B220 versus BrdU expressions on the gated AA4.1+ (top) or AA4.1- (bottom) IgM+ cells from large intestine are shown. The data are representative of three individual experiments. (C and D) Purified AA4.1+ B220+ B cells from the spleen of GFP transgenic mice (left) were intravenously transferred into WT mice with or without prior DSS exposure. 6 d after cell transfer, the recipient mice were killed. GFP- and IgM-expressing B cells in the recipient colon and spleen were identified (C). The expression of CD21 and CD23 versus IgM on the gated GFP+ cells in the spleen and colon of recipient mice without DSS treatment is shown in D. The data are representative of three to six individual recipients/group. (E and F) Purified IgDhigh B cells from the spleen of GFP transgenic mice were intravenously transferred into WT mice that had being treated without (top) or with DSS (bottom). 4 d after cell transfer, the recipient mice were killed. The expressions of GFP versus IgM in recipient spleen (left) and colon (right) are shown in (E). The expressions of CD21 or CD23 on the gated GFP+ cells from the spleen (left) and large intestine (right) of DSS treated mice are shown in (F). The data are representative of three individual recipients.
###end p 15
###begin p 16
###xml 49 50 49 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 271 275 271 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 371 372 371 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 485 486 485 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 490 491 490 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 560 568 560 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 E</xref>
###xml 593 594 593 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 598 599 598 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 686 694 686 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 E</xref>
###xml 738 739 738 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 743 744 743 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 777 778 777 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 783 784 783 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 811 812 811 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 816 817 816 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 848 849 848 849 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 853 854 853 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 856 864 856 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 F</xref>
###xml 893 899 893 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 950 951 950 951 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1011 1012 1011 1012 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1120 1124 1120 1124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 1215 1216 1215 1216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 327 342 <span type="species:ncbi:10090">transgenic mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 546 551 <span type="species:ncbi:10090">mouse</span>
Naive follicular B cells, which mature from AA4.1+ immature B cells, have the ability to recirculate in search of antigens (36). Therefore, we next examined the involvement of recirculating naive B cells in the development of intestinal B cells. To do so, we purified IgDhigh naive recirculating B cells from the spleen of GFP transgenic mice and transferred them (5 x 106) intravenously into WT mice with or without induction of DSS colitis. 4 d after cell transfer, donor-derived GFP+ IgM+ B cells were detected in the spleen of both recipient mouse groups (Fig. 2 E, left). In contrast, GFP+ IgM+ B cells were detectable in the inflamed colon (DSS-treated), but not in normal colon (Fig. 2 E, right). In addition, the reconstituted GFP+ IgM+ B cells in the spleen had a CD21+ CD23+ phenotype, whereas the GFP+ IgM+ B cells in the colon were CD21-CD23- (Fig. 2 F). These data, together with Fig. 2 (B and C) and Fig. S2, support the view that AA4.1- intestinal B cells directly or indirectly mature from AA4.1+ immature B cells in the steady state and that intestinal inflammatory stimuli induce the recruitment of IgDhigh naive recirculating B cells to the intestine, resulting in the significant increase in IgM+ B cells within the inflamed intestine.
###end p 16
###begin title 17
Intestinal B cells exhibit a unique activated phenotype
###end title 17
###begin p 18
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 312 313 312 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 439 447 439 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 551 559 551 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 692 700 692 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 919 925 919 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink">bright</sup>
###xml 931 943 931 943 <sup xmlns:xlink="http://www.w3.org/1999/xlink">intermediate</sup>
###xml 948 951 948 951 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 956 959 956 959 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 965 966 965 966 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 976 979 976 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 1210 1231 1210 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Citrobacter rodentium</italic>
###xml 1315 1323 1315 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 1359 1365 1359 1365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">bright</sup>
###xml 1380 1381 1380 1381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1210 1231 <span type="species:ncbi:67825">Citrobacter rodentium</span>
Because some intestinal B cells originate from the recirculating naive B cell pool, particularly under inflammatory conditions, we next tested whether the intestinal B cells phenotypically resemble naive or activated B cells. The expression of several activation markers (16) was analyzed. Interestingly, the IgM+ intestinal B cells were characterized by remarkably high expression levels of MHC class II in comparison to splenic B cells (Fig. 3 A). The expression levels of MHC class II were comparable on B cells from normal and inflamed intestine (Fig. 3 A). In addition, a slight increase in the expression of CD69 was observed on the intestinal B cells in comparison to splenic B cells (Fig. 3 A). In contrast, no significant up-regulation of Fas, PNA, CD80, or CD86 was found on the intestinal B cells. Therefore, it is possible that intestinal B cells represent a unique activated B cell population that is MHCIIbright, CD69intermediate, Faslow, PNAlow, CD80-, and CD86low. To elucidate whether the phenotype of intestinal B cells represents a response to an intestinal pathogen, and to determine if these cells can be further activated by pathogens, we examined intestinal B cells after infection with Citrobacter rodentium. This infection did not induce the expression of Fas or PNA on intestinal B cells (Fig. 3 B). These data suggest that the MHCIIbright intestinal IgM+ B cell population is not elicited by a known intestinal pathogen, and these cells may represent a unique preactivated B cell population.
###end p 18
###begin p 19
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Unique activated status of intestinal IgM<sup>+</sup> B cells.</bold>
###xml 330 342 330 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. rodentium</italic>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 296 300 <span type="species:ncbi:10090">mice</span>
###xml 306 310 <span type="species:ncbi:10090">Mice</span>
###xml 330 342 <span type="species:ncbi:67825">C. rodentium</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
Unique activated status of intestinal IgM+ B cells. (A) Expressions of IgM versus MHC class II, CD69, Fas, PNA, CD80, or CD86 in cells of the spleen and colon from WT mice (Day 0) and WT mice during recovery phase of DSS colitis (Day 8) are shown. The data are representative of three individual mice. (B) Mice were infected with C. rodentium and killed 6 and 10 d after infection. Expressions of IgM versus PNA or Fas on cells from the normal colon (left) and the infected colon (right) are shown. The data are representative of three individual mice/group. Representative expression patter was observed on the intestinal B cells 6 d after infection (not depicted).
###end p 19
###begin title 20
###xml 26 27 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Functional property of IgM+ B cells in the large intestine
###end title 20
###begin p 21
###xml 61 63 61 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 68 70 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 200 201 200 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 348 349 348 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 352 353 352 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 362 363 362 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 404 412 404 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 577 592 577 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, B and C</xref>
###xml 710 712 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 747 748 747 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 810 811 810 811 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 821 829 821 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 907 908 907 908 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1109 1111 1101 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 1213 1214 1201 1202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1329 1330 1313 1314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1364 1365 1348 1349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1375 1390 1359 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, E and F</xref>
###xml 1424 1425 1408 1409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 963 967 <span type="species:ncbi:10090">mice</span>
Because the intestine is a major source of IgA-plasma cells (17-20, 23-25), the differentiation of activated intestinal B cells into IgA plasma cells was next investigated. Interestingly, although IgM+ B cells were markedly increased in the inflamed mucosa during the recovery phase of DSS colitis, no significant increase in the proportion of B220-IgA+ or CD138+ plasma cells was observed at this site (Fig. 4 A). ELISPOT assay also showed that the absolute number of IgA-secreting cells among total intestinal cells decreased during the recovery phase of DSS colitis (day 8; Fig. 4, B and C). In addition, expression of activation-induced deaminase an enzyme required for class switch recombination and SHM (37, 38) was slightly lower in the IgM+ B cells of the large intestine when compared with splenic IgM+ B cells (Fig. 4 D). To analyze the frequency of SHM, genomic DNA was isolated from purified IgM+ B cells from the large intestine and the spleen of WT mice and subjected to PCR/DNA sequence analysis using a primer set that amplifies rearranged Vkappa4-Jkappa5 light chain segments of genomic DNA (39). There was no significant restriction of Vkappa4 subfamily usages between intestinal and splenic IgM+ B cells. Interestingly, the frequency of SHM within the Vkappa4 segments was significantly lower in intestinal IgM+ B cells compared with splenic IgM+ B cells (Fig. 4, E and F). These findings suggest that IgM+ B cells do not appear to contribute to IgA-producing plasma cells in the large intestine, and they are characterized by the low frequency of SHM.
###end p 21
###begin p 22
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 118 0 118 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Large intestinal IgM<sup>+</sup> B cells are characterized by low frequency of SHM and by production of IL-12 in response to CpG.</bold>
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 520 521 520 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 549 550 549 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 618 619 618 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 727 728 727 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1183 1184 1183 1184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 1225 1226 1225 1226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1578 1579 1577 1578 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1583 1584 1582 1583 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1669 1670 1668 1669 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1705 1706 1704 1705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1724 1725 1723 1724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 750 754 <span type="species:ncbi:10090">mice</span>
###xml 1241 1245 <span type="species:ncbi:10090">mice</span>
###xml 1306 1310 <span type="species:ncbi:10090">mice</span>
###xml 1737 1741 <span type="species:ncbi:10090">mice</span>
Large intestinal IgM+ B cells are characterized by low frequency of SHM and by production of IL-12 in response to CpG. (A) Expressions of IgA and CD138 versus B220 on large intestinal cells from day 0 (n = 6) and day 8 (n = 6) of DSS colitis are shown. (B and C) ELISPOT assay shows the number of IgA-secreting cells among total large intestinal cells at day 0 and 8 of DSS colitis (B). The data are summarized in C. (D) Expressions of activation-induced deaminase in purified B cells from the colon of day 0 (open bar, n = 16) and day 8 (gray bar, n = 15) after DSS treatment and from the spleen of day 0 (black bar, n = 8) are shown. *, P < 0.1; **, P < 0.05. (E) Analysis of sequences with mutations (splenic and colonic IgM+ B cells of normal WT mice) is depicted by pie charts. Numbers outside of each pie chart are the number of mutations/clone. The size of the wedge is proportional to the percentage of clones carrying that number of mutations. Inside each inner circle is the number of clones sequenced. Data from an individual spleen (as control) and two different normal large intestines are shown. (F) Mutation frequencies are calculated by the number of mutations per 104 bp from splenic and large intestinal IgM+ B cells of WT mice. (G) Cells from the normal large intestine and spleen of WT mice were stimulated with 1 muM CpG for 17 h, including a 7-h culture period with GolgiStop. The stimulated cells were subjected to surface staining for detection of IgM and B220 and intracellular staining for detection of IL-12p70. Expression of IL-12p70 in the gated IgM+B220+ cell population is shown. (H) The mean percentage of IL-12-producing cells among IgM+ B cells from the large intestine (n = 6) and spleen (n = 6) of WT mice is shown. *, P < 0.001.
###end p 22
###begin p 23
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
###xml 483 484 483 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 488 489 488 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 610 625 610 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, G and H</xref>
###xml 550 554 <span type="species:ncbi:10090">mice</span>
Several recent studies have suggested that, like T cells, B cells also possess the ability to produce several kinds of cytokines (40-43). We used real-time PCR to primarily screen B cells stimulated with ligands for pattern recognition receptors (including ligands for TLR 2, 4, 5, 7, and 9), and found that IL-12p35 mRNA expression was specifically induced in intestinal B cells after stimulation with CpG (unpublished data). Indeed, flow cytometric analysis clearly showed that IgM+B220+ B cells from the large intestine, but not the spleen, of WT mice produce a large amount of lL-12p70 in response to CpG (Fig. 4, G and H).
###end p 23
###begin title 24
###xml 59 60 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 64 65 64 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
Antigen-independent polyclonal expansion of intestinal CD21-CD23- B cells
###end title 24
###begin p 25
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 659 660 659 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 747 749 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">44</xref>
The intestine is constitutively exposed to a wide spectrum of enteric microorganisms (19). Therefore, we examined the clonality of B cells in the large intestine by analyzing the VDJ region of IgM heavy chains (VHJ558 and VHQ52) to test whether some specific enteric (microbial) antigens cause the expansion of intestinal B cells. There was no restricted diversity of the BCR repertoire of VHJ558 or VHQ52 within the B cells from the normal intestine (Fig. S3 and Fig. S4). Interestingly, a similar polyclonal pattern was also observed in B cells from the inflamed intestine of DSS colitis (Fig. S3 and Fig. S4). These findings suggest that the intestinal IgM+ B cells using VHJ558 and VHQ52, which together account for 65% of the BCR repertoire (44), expand polyclonally.
###end p 25
###begin p 26
###xml 236 237 236 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 467 475 467 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 514 515 514 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 568 576 568 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 611 612 611 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 637 638 637 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 642 643 642 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 655 663 655 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 C</xref>
###xml 759 760 759 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 764 765 764 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1081 1083 1081 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 1084 1086 1084 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 1108 1109 1108 1109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1113 1114 1113 1114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1117 1118 1117 1118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1215 1223 1215 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 D</xref>
###xml 1336 1344 1336 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 E</xref>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
###xml 960 964 <span type="species:ncbi:10090">mice</span>
###xml 1187 1191 <span type="species:ncbi:10090">mice</span>
To further test the antigen specificity of intestinal B cell development, we generated IghelMD4 Tg x RAG1 KO mice; these mice contain only a monoclonal B cell population that expresses a restricted BCR specific for hen egg lysozyme. IgM+ B cells were still detected in the intestines of these mice in the absence of any inflammatory stimulus, and a marked expansion of these B cells occurred in the inflamed mucosa during the recovery phase from DSS-induced colitis (Fig. 5 A). As seen in WT mice, the expanded IgM+ B cells formed clusters within the inflamed mucosa (Fig. 5 B). In addition, the majority of IgM+ B cells were of the CD21-CD23- phenotype (Fig. 5 C). These findings suggest that antigen/BCR interactions may not be essential for intestinal CD21-CD23- B cell development. It however cannot be ruled out that some self-antigen that cross-reacts with hen egg lysozyme exists. To further explore the role of antigens and the BCR, we investigated KO mice deficient in Bruton's tyrosine kinase (Btk) or Lyn, both of which play a crucial role in the BCR signaling cascade (45-47). Interestingly, CD21-CD23-IgM+ B cells were detectable at normal levels in the intestines of these mice in the absence of DSS (Fig. 5 D), and they were significantly increased within the inflamed intestine during the recovery phase of DSS colitis (Fig. 5 E).
###end p 26
###begin p 27
###xml 0 30 0 30 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Development of intestinal CD21</bold>
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 31 35 31 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CD23</bold>
###xml 35 36 35 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 36 97 36 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B cells through BCR-independent response without T cell help.</bold>
###xml 124 125 124 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 215 216 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 277 278 277 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 461 462 461 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 593 594 593 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 738 739 738 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 790 791 790 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 814 815 814 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 876 877 876 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 940 941 940 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 994 995 994 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1303 1304 1303 1304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1406 1407 1399 1400 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1497 1498 1483 1484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1553 1554 1539 1540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1722 1723 1701 1702 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 324 328 <span type="species:ncbi:10090">mice</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
###xml 662 666 <span type="species:ncbi:10090">mice</span>
###xml 784 788 <span type="species:ncbi:10090">mice</span>
###xml 808 812 <span type="species:ncbi:10090">mice</span>
###xml 907 911 <span type="species:ncbi:10090">mice</span>
###xml 1127 1131 <span type="species:ncbi:10090">mice</span>
###xml 1363 1367 <span type="species:ncbi:10090">mice</span>
###xml 1464 1468 <span type="species:ncbi:10090">mice</span>
###xml 1622 1626 <span type="species:ncbi:10090">mice</span>
Development of intestinal CD21-CD23-B cells through BCR-independent response without T cell help. (A) Absolute number of IgM+ cells in the large intestine from lghelMD4 tg x RAG1 KO mice at day 0 (normal, open bar; n = 10) and day 8 (recovery phase of DSS colitis, shaded bar; n = 10) are shown. (B) Colonic tissues from WT mice at day 8 and from lghelMD4 tg x RAG1 KO mice at days 0 and 8 were subjected to immunohistochemical analysis for the detection of IgM+ cells. The findings are representative of >12 individual experiments. (C) Expressions of IgM versus CD21 or CD23 on the gated B220+ cells of normal large intestine (Day 0) from lghelMD4 tg x RAG1 KO mice are shown. (D) Expressions of IgM versus CD21 or CD23 on the gated B220+ cells from normal large intestine of Btk KO mice (n = 5) and Lyn KO mice (n = 5) are shown. (E) Absolute numbers of large intestinal IgM+ cells from Btk KO and Lyn KO mice at day 0 (normal, open bar, n = 5) and day 8 of DSS colitis (recovery, solid bar, n = 5-7) are shown. (F) Inflamed intestinal mucosa (Day 8 of DSS colitis, top) and colonic patch within normal mucosa (bottom) of WT mice were subjected to immunohistochemical analysis for the detection of IgM (left), CD3 (middle), and FDC (right). (G) Expressions of IgM versus CD21 or CD23 on the gated B220+ cells of the normal large intestine from TCRbetadelta DKO mice are shown. (H) Absolute numbers of IgM+ cells in the large intestine of WR and TCRbetadelta DKO mice at day 0 (normal, open bar, n = 5-7) and day 8 (recovery of DSS colitis, solid bar; n = 5-7) are shown. (I) Large intestinal tissues of TCRbetadelta DKO mice at day 8 of DSS colitis were subjected to immunohistochemical analysis for the detection of IgM+ cells. Statistical significances are indicated in by ** (P < 0.001). Bars, 100 mum.
###end p 27
###begin title 28
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
T cell help is not required for intestinal CD21-CD23- B cell development or expansion
###end title 28
###begin p 29
###xml 169 177 169 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 F</xref>
###xml 347 355 347 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 F</xref>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib48">48</xref>
###xml 555 563 555 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 F</xref>
###xml 779 780 757 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 784 785 762 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 825 826 803 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 878 886 849 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 G</xref>
###xml 1073 1081 1037 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 H</xref>
###xml 1093 1094 1057 1058 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1184 1192 1141 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 I</xref>
###xml 1267 1268 1224 1225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1272 1273 1229 1230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1428 1429 1385 1386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 689 693 <span type="species:ncbi:10090">mice</span>
###xml 769 773 <span type="species:ncbi:10090">mice</span>
###xml 872 876 <span type="species:ncbi:10090">mice</span>
###xml 972 976 <span type="species:ncbi:10090">mice</span>
###xml 997 1001 <span type="species:ncbi:10090">mice</span>
###xml 1178 1182 <span type="species:ncbi:10090">mice</span>
Interestingly, expansion of intestinal B cells after an inflammatory stimulus resulted in the formation of B cell clusters with a unique pattern of T cell localization (Fig. 5 F); T cells were present around B cell clusters rather than in well-defined T cell areas, as normally seen in resident organized lymphoid tissues such as colonic patches (Fig. 5 F) (48). In addition, follicular dendritic cells (FDCs) were not detectable within the B cell clusters, whereas scattered FDCs were normally present within the follicles of organized lymphoid tissues (Fig. 5 F). Therefore, we next examined the role of T cells during intestinal B cell development by using TCRbetadelta double KO (DKO) mice that have no TCRalphabeta or TCRgammadelta T cells. Just as was seen in WT mice, CD21-CD23- B cells represented the majority of IgM+ B cells in the intestine of TCRbetadelta DKO mice (Fig. 5 G). Interestingly, intestinal B cells were significantly increased in TCRbetadelta DKO mice as compared with WT mice both in the absence of inflammation and under inflammatory conditions (Fig. 5 H). Large IgM+ B cell clusters were also recognized in the inflamed intestine of TCRbetadelta DKO mice (Fig. 5 I). These findings suggest that T cells are not required for intestinal CD21-CD23- B cell development in a state of health and during inflammation, but may contribute to the suppression of the development or recruitment of intestinal IgM+ B cells.
###end p 29
###begin title 30
###xml 15 16 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
Intestinal CD21-CD23- B cells develop in the absence of both the spleen and organized lymphoid tissues
###end title 30
###begin p 31
###xml 78 80 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 81 83 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 113 114 106 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 191 193 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 195 197 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 199 201 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 240 241 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 245 246 238 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 307 309 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 310 312 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 334 335 323 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 339 340 328 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 391 399 376 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 A</xref>
###xml 503 518 488 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, B and C</xref>
###xml 524 525 509 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 584 592 565 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 D</xref>
###xml 639 640 620 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 644 645 625 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 868 870 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 872 874 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 286 290 <span type="species:ncbi:10090">mice</span>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
###xml 578 582 <span type="species:ncbi:10090">mice</span>
The LT-alpha1beta2 signaling cascade is required for the development of GALT (20-22). Because some intestinal IgA+ plasma cells have been shown to be derived from GALT, particularly from PP (17, 20, 23), we examined the role of GALT in CD21-CD23- B cell development by using LTalpha KO mice that lack GALT (20-22). Interestingly, CD21-CD23- B cells were still detectable in LTalpha KO mice (Fig. 6 A), and a marked expansion of these B cells was induced in the inflamed intestine after exposure to DSS (Fig. 6, B and C). IgM+ B cell clusters were still detectable in LTalpha KO mice (Fig. 6 D). These findings indicate that intestinal CD21-CD23- B cells develop even in the absence of GALT, which is consistent with previous reports showing that naive B cells can directly migrate into the small intestinal mucosa through a pathway different from GALT-primed B cells (24, 25).
###end p 31
###begin p 32
###xml 0 15 0 15 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Intestinal CD21</bold>
###xml 15 16 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 16 20 16 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CD23</bold>
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 21 99 21 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B cell development is independent of spleen and organization lymphoid tissues.</bold>
###xml 150 151 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 164 165 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 194 195 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 208 209 204 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 265 266 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 279 280 267 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 417 424 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#949;</italic>
###xml 516 517 494 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 759 760 729 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 828 829 798 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 286 290 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 683 687 <span type="species:ncbi:10090">mice</span>
###xml 895 899 <span type="species:ncbi:10090">mice</span>
Intestinal CD21-CD23-B cell development is independent of spleen and organization lymphoid tissues. Intestinal inflammation was induced in WT (Day 0, n = 8; Day 8, n = 8) and LTalpha KO (Day 0, n = 5; Day 8, n = 5) and splenectomized LTalpha (SP[-] LTalpha; Day 0, n = 5; Day 8, n = 5) mice. (A) Expressions of IgM versus CD21 or CD23 on large intestinal cells from LTalpha KO mice are shown. (B) Proportions (IgM/CD3epsilon) in large intestinal cells at day 8 are shown. (C) Absolute numbers of large intestinal IgM+ cells at day 0 (normal, open bar) and day 8 (recovery, shaded bar) are shown. (D and E) The inflamed intestine from LTalpha KO (D) and splenectomized LTalpha KO (E) mice were subjected to immunohistochemical analysis for the detection of IgM+ cells. (F) Expressions of IgM versus CD21 or CD23 on the gated B220+ cells from the normal colon (Day 0) of splenectomized LTalpha KO mice are shown. Bars, 100 mum.
###end p 32
###begin p 33
###xml 88 89 88 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 90 91 90 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 93 94 93 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 156 157 156 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 161 162 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 166 167 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 208 209 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 506 507 498 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 511 512 503 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 524 532 516 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 F</xref>
###xml 649 664 641 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, C and E</xref>
###xml 773 774 765 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 778 779 770 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 920 921 912 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 415 419 <span type="species:ncbi:10090">mice</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
Peripheral B cells complete their maturation through transitional stages in the spleen (1-6, 8, 34). Like recirculating follicular B cells, intestinal AA4.1-CD21-CD23- B cells also appear to mature from AA4.1+ immature B cells. Therefore, to test the role of the splenic environment during intestinal B cell development, we used splenectomized LTalpha KO mice in which both the spleen and GALT were absent. Like WT mice, the majority of intestinal B cells in splenectomized LTalpha KO mice were of the CD21-CD23- phenotype (Fig. 6 F), and a marked expansion of these B cells with cluster formation was observed during the recovery from DSS colitis (Fig. 6, C and E). These results indicate that neither the spleen nor GALT is required for the development of intestinal CD21-CD23- B cells, and that in the absence of spleen, the intestinal B cells may be recruited from recirculating naive B cells that mature in the BM (7) and/or from BM-derived immature AA4.1 B cells.
###end p 33
###begin title 34
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
Insufficient evidence to suggest a linkage between intestinal CD21-CD23- B cells and B1 lineage cells
###end title 34
###begin p 35
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 164 165 164 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 169 170 169 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 316 317 316 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 441 442 441 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 446 447 446 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 538 539 538 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 589 597 589 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 A</xref>
###xml 716 718 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">49</xref>
###xml 720 722 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 816 818 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">51</xref>
###xml 835 836 831 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 914 929 910 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, B and C</xref>
###xml 1034 1042 1030 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 D</xref>
###xml 1091 1092 1087 1088 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1267 1282 1263 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, B and C</xref>
###xml 1357 1358 1353 1354 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1363 1364 1359 1360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1374 1375 1370 1371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1386 1394 1382 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 E</xref>
###xml 1463 1464 1459 1460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
###xml 386 390 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 648 652 <span type="species:ncbi:10090">mice</span>
###xml 763 767 <span type="species:ncbi:10090">mice</span>
###xml 908 912 <span type="species:ncbi:10090">mice</span>
###xml 1013 1017 <span type="species:ncbi:10090">mice</span>
###xml 1148 1152 <span type="species:ncbi:10090">mice</span>
###xml 1231 1236 <span type="species:ncbi:10090">mouse</span>
###xml 1421 1425 <span type="species:ncbi:10090">mice</span>
IgA+ plasma cells in the small intestine have previously been demonstrated to originate from peritoneal B1 cells (18, 23). Therefore, we sought to determine if CD21-CD23- B cells in the large intestine might be derived from B1 B cells. To test this possibility, RAG-1 KO mice were reconstituted with peritoneal CD11b+ cells from WT mice, which include B1 cells and macrophages, and the mice were subsequently treated with DSS. Although CD11b+ IgM+ B1 cells could be recognized in the peritoneal cavity of the recipient RAG KO mice, no IgM+ cells were detectable in the inflamed intestine (Fig. 7 A). We next examined IL-7 receptor alpha (IL-7R) KO mice in which the development of B2, but not B1, cells is impaired (49, 50) and Rac2 (guanosine triphosphatase) KO mice that show the impaired development of B1 cells (51). Only a few IgM+ cells were detectable in the normal and inflamed intestine of IL-7R KO mice (Fig. 7, B and C). In addition, no B cell clusters were observed in the inflamed mucosa of IL-7R KO mice exposed to DSS (Fig. 7 D). In contrast, there were similar numbers of IgM+ B cells in the normal intestine between Rac2 KO and WT mice, and significant B cell expansion was observed in the inflamed mucosa of both mouse groups after exposure to DSS (Fig. 7, B and C). These findings, together with the phenotype of intestinal B cells (CD11b-, CD5-, and CD43-) shown in Fig. 1 E, and the data from Btk KO mice, all suggest that the majority of IgM+ B cells in the large intestine may originate from conventional B2 lineage cells.
###end p 35
###begin p 36
###xml 0 15 0 15 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Intestinal CD21</bold>
###xml 15 16 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 16 20 16 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CD23</bold>
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 24 25 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 21 73 21 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IgM<sup>+</sup> B cells are not associated with B1 lineage cell</bold>
###xml 282 285 282 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 289 290 289 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 352 353 352 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 546 547 546 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 560 561 560 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 584 585 584 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 598 599 598 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 632 633 628 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 646 647 642 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 767 768 757 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 992 993 978 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
###xml 484 488 <span type="species:ncbi:10090">mice</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
###xml 912 916 <span type="species:ncbi:10090">mice</span>
###xml 1077 1081 <span type="species:ncbi:10090">mice</span>
Intestinal CD21-CD23-IgM+ B cells are not associated with B1 lineage cell. (A) RAG1 KO mice that had been reconstituted with peritoneal B1 cells from WT mice were treated with 4% DSS for 4 d and killed at day 8. The DSS-treated recipient mice show sufficient reconstitution of CD11blow IgM+ B 1 cells in the peritoneal cavity (PC, left), whereas no IgM+ B cells are detectable in the inflamed mucosa (LP, right) of these mice. The data are representative of four individual recipient mice. (B-D) Intestinal inflammation was induced in WT (Day 0, n = 6; Day 8, n = 6), Rac2 KO (Day 0, n = 5; Day 8, n = 5), and IL-7Ralpha KO (Day 0, n = 5; Day 8, n = 5) mice by oral administration of 4% DSS for 4 d. Proportion (IgM/CD3epsilon) at day 8 (B) and absolute number of IgM+ cells in the large intestine at day 0 (normal, open bar) and day 8 (recovery, shaded bar; C) are shown. The large intestine from IL-7Ralpha KO mice at day 8 was subjected to immunohistochemical analysis for detection of IgM+ cells (D). Presence of statistical significance (P < 0.001) compared with day 8 WT mice is indicated by **. Bars, 100 mum.
###end p 36
###begin title 37
###xml 29 30 29 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
Dependence of intestinal CD21-CD23- B cells on BAFF-R signaling cascade
###end title 37
###begin p 38
###xml 300 301 300 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 613 614 613 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 615 616 615 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 626 628 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">52</xref>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib53">53</xref>
###xml 805 813 805 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 A</xref>
###xml 843 844 843 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 937 945 937 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 A</xref>
###xml 1076 1078 1068 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">54</xref>
###xml 1080 1082 1072 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">55</xref>
###xml 1247 1249 1239 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">56</xref>
###xml 1331 1333 1323 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib57">57</xref>
###xml 1433 1434 1425 1426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1517 1525 1509 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 A</xref>
###xml 1664 1672 1656 1664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 A</xref>
###xml 1829 1837 1817 1825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 B</xref>
The rapid expansion of intestinal B cells by DSS-induced intestinal inflammation provided an opportunity to closely examine the molecular events involved in intestinal B cell development and/or recruitment. We therefore performed a real-time PCR-based screening approach using purified intestinal IgM+ B cells from day 0 (normal), 4 (acute colitis), and 8 (recovery phase of colitis with B cell expansion) of DSS colitis to analyze the expression of 276 molecules that have been demonstrated to play crucial roles in the genesis, differentiation, maturation, apoptosis/survival, homing and activation of B cells (1-6, 46, 47, 52, 53). We found that receptor of B cell activation factor from the TNF family (BAFF-R) is specifically up-regulated in intestinal B cells on day 8 as compared with day 4 and 0 (Fig. 8 A). In contrast, intestinal IgM+ B cells did not express BCMA (B cell maturation antigen) during the course of inflammation (Fig. 8 A). BAFF-R engagement promotes processing of NF-kappaB2 protein p100 to p52, which is dependent on NF-kappaB-inducing kinase (NIK) (54, 55). Recent studies indicate that activation of the BAFF-R signaling cascade up-regulates Pim2 (a prosurvival kinase) and Bim (a BH3-only member of the Bcl-2 family) (56), and that BAFF-R signaling is negatively regulated by an adaptor protein, Act1 (57). Indeed, a significant up-regulation of NIK, Pim2, and Bim was observed in purified intestinal IgM+ B cells during the recovery, but not the acute, phase of intestinal inflammation (Fig. 8 A). In contrast, expression of Act-1 was significantly down-regulated in B cells during the course (both day 4 and 8) of this inflammation (Fig. 8 A). In addition, enhanced processing of NF-kappaB2 protein p100 to p52 in intestinal B cells was specifically observed in the recovery phase of inflammation (Fig. 8 B).
###end p 38
###begin p 39
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Requirement of BAFF-R&#8211;mediated signaling for intestinal CD21</bold>
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 61 65 61 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CD23</bold>
###xml 65 66 65 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 66 85 66 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B cell development.</bold>
###xml 585 586 579 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 844 845 838 839 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1001 1002 995 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1015 1016 1009 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1054 1055 1048 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1068 1069 1062 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1179 1180 1173 1174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1536 1537 1530 1531 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1576 1577 1570 1571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1724 1725 1718 1719 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1741 1742 1735 1736 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1785 1786 1777 1778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1834 1835 1824 1825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
###xml 909 913 <span type="species:ncbi:10090">mice</span>
###xml 1041 1045 <span type="species:ncbi:10090">mice</span>
###xml 1235 1239 <span type="species:ncbi:10090">mice</span>
###xml 1347 1351 <span type="species:ncbi:10090">mice</span>
###xml 1420 1424 <span type="species:ncbi:10090">mice</span>
###xml 1447 1451 <span type="species:ncbi:10090">mice</span>
###xml 1597 1601 <span type="species:ncbi:10090">mice</span>
###xml 1620 1624 <span type="species:ncbi:10090">mice</span>
###xml 1779 1783 <span type="species:ncbi:10090">mice</span>
###xml 1828 1832 <span type="species:ncbi:10090">mice</span>
Requirement of BAFF-R-mediated signaling for intestinal CD21-CD23-B cell development. (A) Expressions of BAFF signaling-related molecules in purified B cells from the large intestine of day 0 (open bars), 4 (gray bars), and 8 (black bars) after DSS treatment and from the spleen of day 0 (hatched bars) are shown. The results represent the means +/- the SD from six individual mice in each group. *, P < 0.00 1 (comparison between colonic B cells at day 0 versus day 8). (B) Western blot analysis shows the expression levels of NF-kappaB2 p100 and p52 in purified B cells (>97% are IgM+) of the large intestine from 4-30 pooled WT mice at day 0 (D0, normal) and 8 (D8, recovery of DSS colitis), and of the spleen from day 0. The data are representative of two individual experiments. (C) Expressions of IgM versus CD21 or CD23 on the gated B220+ cells from normal large intestine of control and BAFF-R mutant mice are shown. (D-G) Intestinal inflammation was induced in BAFF-R mutant (A/WySnJ; Day 0, n = 5; Day 8, n = 16) and control (A/J) mice (Day 0, n = 5; Day 8, n = 10) by oral administration of 4% DSS for 4 d. (D and E) Proportion (CD3/IgM; D) and absolute numbers of IgM+ B cells (E) in the colon of control and BAFF-R mutant mice at day 8 of DSS colitis are shown. Presence of statistically significant (P < 0.001) compared with control mice at day 8 is indicated by **. (F and G) Large intestine from control mice (F) and BAFF-R mutant mice (G) at day 8 were subjected to immunohistochemical analysis for the detection of IgM+ cells. (H) Apoptosis of intestinal IgM+ B cells in control mice and BAFF-R mutant mice at day 8 of DSS colitis as judged by Annexin V staining is shown. The mean percentages of Annexin V+ cells among IgM+ cells are 36.6 +/- 1.09% in control mice (n = 7) and 75.6 +/- 1.64% in BAFF-R mutant mice (n = 7; P < 0.001). (I) Expression of AA4.1 versus B220 on the cells from normal intestine of control (left) and BAFF-R mutant (right) are shown. Bars, 100 mum.
###end p 39
###begin p 40
###xml 78 79 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 83 84 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">54</xref>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">56</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">58</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib59">59</xref>
###xml 230 231 230 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 235 236 235 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 327 335 327 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 C</xref>
###xml 418 419 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 423 424 423 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 428 429 428 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 461 476 461 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8, D and E</xref>
###xml 558 566 558 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 F</xref>
###xml 596 604 596 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 G</xref>
###xml 736 744 736 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 H</xref>
###xml 830 832 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">54</xref>
###xml 833 835 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib59">59</xref>
###xml 865 866 865 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 978 986 978 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 I</xref>
###xml 1264 1266 1264 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">58</xref>
###xml 1268 1270 1268 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib60">60</xref>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
###xml 590 594 <span type="species:ncbi:10090">mice</span>
###xml 730 734 <span type="species:ncbi:10090">mice</span>
###xml 942 946 <span type="species:ncbi:10090">mice</span>
###xml 972 976 <span type="species:ncbi:10090">mice</span>
To further examine the role of the BAFF-R signaling cascade in intestinal CD21-CD23- B cell development, we analyzed BAFF-R mutant (A/WySnJ) and A/J (control) mice (54-56, 58, 59). Interestingly, intestinal B cells exhibiting CD21-CD23- phenotype were significantly reduced in BAFF-R mutant mice as compared with control mice (Fig. 8 C). In addition, DSS-induced colitis failed to induce a significant expansion of IgM+CD21-CD23- B cells in BAFF-R mutant mice (Fig. 8, D and E). Indeed, B cell clusters within the inflamed mucosa were detectable in control (Fig. 8 F) but not BAFF-R mutant mice (Fig. 8 G). In addition, significantly enhanced apoptosis of intestinal B cells was observed in BAFF-R mutant as compared with control mice (Fig. 8 H), which is consistent with an important role of BAFF-R signaling in B cell survival (54-59). In addition, immature AA4.1+ B cells in the large intestine were significantly reduced in BAFF-R mutant mice as compared with control mice (Fig. 8 I). These findings suggest that the BAFF-R-associated signaling pathway plays a crucial role in intestinal B cell development and homeostasis. They are consistent with a role for BAFF-R in all B2 populations after the T1 stage and the absence of a role for BAFF-R in B1 B cells (58, 60).
###end p 40
###begin title 41
DISCUSSION
###end title 41
###begin p 42
###xml 83 84 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 138 139 138 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 143 144 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 148 149 148 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 154 160 154 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">bright</sup>
###xml 563 564 556 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 598 600 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 602 604 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 606 608 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 610 612 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 614 616 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 696 698 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 700 702 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 704 706 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 708 710 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 712 714 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 716 718 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 719 721 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 783 784 776 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 819 820 812 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 824 825 817 818 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 829 830 822 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1017 1018 1010 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1139 1141 1132 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 1143 1145 1136 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 1287 1288 1280 1281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1292 1293 1285 1286 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1297 1298 1290 1291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1303 1309 1296 1302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">bright</sup>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
In this study, we have described a previously unidentified, intestine-specific, IgM+ B cell subset that is characterized by a unique AA4.1-CD21-CD23-MHCIIbright surface phenotype, low frequency of SHM, and the ability to secrete IL-12 in response to a TLR ligand. This B cell subset exists in the normal mucosa of the large intestine and expands in the inflamed mucosa of mice with acute or chronic colitis. The LTalpha1beta2 signaling cascade is required for the development of organized lymphoid tissues (such as PP) that provide a site of origin of some of IgA+ plasma cells in small intestine (17, 18, 20, 23, 24). Most other small intestinal plasma cells originate from peritoneal B1 cells (17, 18, 20, 23, 24, 26-28). We herein describe an additional pathway for intestinal IgM+ B cell development, in which AA4.1-CD21-CD23- B cells in the large intestine are supplied from B2 lineage cells that do not require organized lymphoid tissues for their development. Indeed, recent studies have revealed that some IgM+ B cells in the small intestine are derived from the BM through a pathway distinct from that used by gut-primed B cells (24, 25). Although the phenotype of BM-derived small intestinal B cells has not been characterized in previous studies, it is possible that the AA4.1-CD21-CD23-MHCIIbright B cells in the large intestine characterized in this study may have a counterpart in the small intestine.
###end p 42
###begin p 43
###xml 91 92 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 94 95 94 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 97 98 97 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 100 101 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 177 178 177 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 181 182 181 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 220 221 220 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 273 274 273 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 278 279 278 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 361 362 361 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 367 368 367 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib61">61</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib63">63</xref>
###xml 584 585 584 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 589 590 589 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 820 821 820 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 825 826 825 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 950 954 950 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
Recirculating B cells mature through transitional stages in the spleen, as well as the BM (2, 3, 5, 8). Our BrdU labeling and cell transfer studies suggest that intestinal AA4.1-IgM+ B cells can be derived from the AA4.1+ immature B cell pool. In addition, intestinal AA4.1-CD23- B cells were virtually absent in BAFF-R mutant mice in which development of AA4.1+ CD23+ T2 transitional B cells is defective and T1 transitional/newly formed B cells accumulate (61-63). Therefore, it is likely that recirculating T2 B cells that mature from T1 cells in the spleen seed the intestinal IgM+CD21- B cell compartment in the steady state, down-regulating CD23 when they enter the intestinal milieu. Soon after they seed the intestine, they may continue to express AA4.1, which is a marker of recent maturation. In addition, CD21-CD23- B cells may accumulate in the intestine after the recruitment to the inflamed intestine of cells from the recirculating IgDhigh naive B cell pool that contains both T2 cells and more mature recirculating follicular B cells. Therefore, it may be inferred that inflammatory chemokines and cytokines participate in the recruitment of recirculating B cells to the intestine during inflammation.
###end p 43
###begin p 44
###xml 107 108 107 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 256 257 256 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 260 261 260 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 351 357 351 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 454 460 454 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 529 530 529 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 533 534 533 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 602 603 602 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 606 607 606 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 842 844 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 904 905 904 905 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 955 956 955 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 959 960 959 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Peripheral B cell maturation in the spleen and BM depends in part on BCR-linked positive selection events (2, 5, 9). Interestingly, although inflammatory conditions generally induce a restriction of BCR clonality (12), our data showed that intestinal AA4.1-IgM+ B cells polyclonally expand even in the presence of intestinal inflammation (Fig. S3 and Fig. 4). In addition, B cells with a restricted BCR expanded readily in normal and inflamed intestine (Fig. 3). Furthermore, T cell help was not required for the intestinal AA4.1-IgM+ B cell development. Importantly, a large number of intestinal AA4.1-IgM+ B cells were still detectable even in the absence of Btk or Lyn, which are major signaling molecules involved in BCR-mediated signaling. In addition, SHM that is often induced in mature B cells after encounter with specific antigens (38) was detectable at very low frequency in the intestinal IgM+ B cells. These data suggest that intestinal AA4.1-IgM+ B cells that are constitutively exposed to enteric microorganisms may develop or expand through a BCR-independent pathway.
###end p 44
###begin p 45
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 420 441 420 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Citrobacter rodentium</italic>
###xml 502 503 502 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 826 828 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib64">64</xref>
###xml 1028 1030 1028 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">41</xref>
###xml 1031 1033 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
###xml 1065 1066 1065 1066 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1253 1255 1253 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib65">65</xref>
###xml 1296 1297 1296 1297 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 420 441 <span type="species:ncbi:67825">Citrobacter rodentium</span>
Our data demonstrated that intestinal IgM+ B cells express remarkably high levels of MHC class II. In contrast, several conventional markers expressed on activated splenic B cells, were not expressed by intestinal B cells. The unique expression profile of activation markers was not altered under several intestinal inflammatory conditions, including spontaneous chronic colitis, a chemically induced acute colitis, and Citrobacter rodentium infection. Therefore, it is possible that the intestinal IgM+ B cell population may represent a unique preactivated B cell population presumably caused by the constitutive exposure to enteric microorganisms in the intestine. B cells have generally been believed not to produce IL-12p70, as this cytokine was detectable only in EBV-transformed B cells but not normal systemic B cells (64). However, recent accumulating studies have identified the potential ability of B cells to produce IL-12p70 under certain inflammatory and stimulatory (e.g., combination of CpG and CD40) conditions (41-43). Interestingly, intestinal IgM+ B cells showed the ability to easily produce IL-12p70 in response to a microbial product CpG. Because IL-12p70 is a well known cytokine required for safeguarding against microorganisms (65), it is possible that the intestinal IgM+ B cells may contribute to preserve appropriate host-microbe interaction.
###end p 45
###begin p 46
###xml 58 59 58 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 63 64 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 74 80 74 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">bright</sup>
###xml 121 122 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
In summary, we have identified an intestine-specific AA4.1-CD21-CD23-MHCIIbright B cell subset that is derived from AA4.1+ immature B cells and from recirculating naive B cells. This maturation of these cells represents a distinct pathway of B cell development that occurs in a tissue site, rather than in the BM or the spleen.
###end p 46
###begin title 47
MATERIALS AND METHODS
###end title 47
###begin title 48
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 48
###begin p 49
###xml 378 380 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 568 570 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
###xml 396 401 <span type="species:ncbi:10090">mouse</span>
###xml 518 522 <span type="species:ncbi:10090">mice</span>
###xml 573 577 <span type="species:ncbi:10090">Mice</span>
TCRbetadelta DKO, RAG-1 KO, IL-7Ralpha KO, Rac2 KO, Lyn KO, Btk KO, LTalpha KO, IghelMD4 Tg, GFP Tg mice of C57BL/6 background, BAFF-R mutant (A/WySnJ), and control (A/J) mice were obtained from The Jackson Laboratory and maintained in specific pathogen-free facilities at Massachusetts General Hospital. IghelMD4 Tg mice were crossed with RAG1 KO mice as previously described (40) to generate a mouse strain that possesses monoclonal B cells. Splenectomy and sham operations were performed on anesthetized LTalpha KO mice at 3 d after birth, as previously described (35). Mice were used according to the protocol approved by the Massachusetts General Hospital Animal Care and Use Committee.
###end p 49
###begin title 50
###xml 40 52 40 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. rodentium</italic>
###xml 40 52 <span type="species:ncbi:67825">C. rodentium</span>
DSS-induced intestinal inflammation and C. rodentium infection.
###end title 50
###begin p 51
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 435 447 435 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. rodentium</italic>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib66">66</xref>
###xml 653 654 641 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8</sup>
###xml 662 675 650 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. rodentium)</italic>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 296 300 <span type="species:ncbi:10090">mice</span>
###xml 402 406 <span type="species:ncbi:10090">Mice</span>
###xml 435 447 <span type="species:ncbi:67825">C. rodentium</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
###xml 627 632 <span type="species:ncbi:10090">mouse</span>
###xml 662 674 <span type="species:ncbi:67825">C. rodentium</span>
###xml 677 681 <span type="species:ncbi:10090">Mice</span>
Female (10-12 wk of age) mice were administered 4% DSS (MW: 36,000-50,000, ICN Biomedicals) in drinking water for 4 d, and the DSS administration was then terminated to induce recovery from acute inflammation by changing the DSS water to normal drinking water as previously described (33). These mice were killed on day 0, 4, 8, 14, and 30 after induction of DSS-induced acute intestinal inflammation. Mice were orally inoculated with C. rodentium (strain DBS100; American Type Culture Collection), as previously described (66). Bacteria were grown overnight in Luria broth and resuspended in PBS before infecting mice (0.5 ml/mouse; approximately5 x 108 CFU of C. rodentium). Mice were killed on day 5 and 10 after infection.
###end p 51
###begin title 52
Cell preparation and B cell isolation.
###end title 52
###begin p 53
Large intestine and parts of small intestine containing PP were incubated with 1.5 mg/ml dispase to remove epithelial cells. The remaining tissues were then incubated with 0.8 mg/ml collagenase for 20 min. After passing them through a glass wool column, the mucosal cells were further enriched by Percoll gradient (40/72%) centrifugation. MLNs and spleen were dispersed using 27-gauge needles, and red blood cells were removed using ACK solution. For purifying B cells, cells were incubated with PE-conjugated anti-Ig (Invitrogen) at 4degreesC for 30 min, and then incubated with the anti-PE microbeads at 4degreesC for 30 min. After washing, the labeled cells were isolated using the MACS system (Miltenyi Biotec).
###end p 53
###begin title 54
Cell transfer.
###end title 54
###begin p 55
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 56 60 56 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 260 261 260 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 370 371 370 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 492 493 492 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 107 122 <span type="species:ncbi:10090">transgenic mice</span>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 567 571 <span type="species:ncbi:10090">mice</span>
Immature AA4.1+ B220+ B cells or recirculating naive IgDhigh B cells were purified from the spleens of GFP transgenic mice (5-20 mice). After enrichment of B cells using the MACS system, B cell populations were purified using flow cytometry and sorting. 5 x 106 purified B cells were intravenously transferred into WT mice with or without DSS treatment. Peritoneal CD11b+ cells were purified from pooled WT mice (day 5) using a magnetic cell separation (MACS) system (Miltenyi Biotec). 5 x 106 purified cells were transferred intraperitoneally into recipient RAG1 KO mice that subsequently received DSS orally.
###end p 55
###begin title 56
Phenotypic analysis.
###end title 56
###begin p 57
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 258 265 258 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#949;</italic>
###xml 835 836 828 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 883 885 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 996 998 989 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib67">67</xref>
###xml 1037 1044 1030 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#949;</italic>
Cells were isolated from the large intestine (excluding the cecum), MLN, spleen, PP, and BM as previously described (33). The mAbs used were FITC-, PE-, PerCP-, APC-, or biotin (followed by incubation with PerCP-streptavidin)-conjugated anti-CD1d (1B1), -CD3epsilon (145-2C11), -CD5 (53-7.3), -CD9 (KMC8), -CD11b (M1/70), -CD21 (7G6), -CD23 (B3B4), -CD24 (M1/69), -CD43 (S7), -CD69 (H1,2F3), -B220 (RA3-6B2), -CD62L (hen egg lysozyme-14), -CD138 (282-2), -IgD (11-26C2a), -Fas (Jo2; BD Biosciences), -IgA (SouthernBiotech), -AA4.1, -CD80 (16-10A1), -CD86 (GL1), MHC-II (M5/114, 15.2; eBioscience), -Igmu (Caltag), -IL-12p70 (BioLegend), and FITC-PNA (Vector Laboratories). Annexin V staining was performed according to the manufacturer's instructions (BD Biosciences). BrdU pulse labeling and nuclear staining for the detection of BrdU+ cells were performed as previously described (35). Immunohistochemical staining was performed using the avidin-biotin complex method, as previously described (67). The mAbs used were purified anti-CD3epsilon, -IgM, -IgD, and -FDC.
###end p 57
###begin title 58
Intracellular cytokine staining.
###end title 58
###begin p 59
Spleen and large intestinal cells were stimulated either with or without 1 muM CpG (InvivoGen) for 17 h. GolgiStop (BD Bioscience) was added during the last 7 h. The cells were first stained with FITC-conjugated anti-B220 (RA3-6B2) and APC-conjugated anti-Igmu antibody, and then they were fixed and permeabilized with Cytofix/Cytoperm solution. The cells were then stained intracellularly with PE-conjugated anti-IL-12p70. After washing, the cells were immediately subjected to flow cytometric analysis.
###end p 59
###begin title 60
Ig secretion and proliferation of B cells.
###end title 60
###begin p 61
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 297 298 297 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 341 342 340 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 459 461 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 494 495 491 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 343 347 <span type="species:ncbi:9925">goat</span>
Cells were subjected to ELISPOT assay for the detection of IgA-secreting cells as previously described (32). For proliferation assay, B cells were enriched by negative sorting for depletion of CD3-, Gr1-, DX5-, and CD11c-expressing cells, as previously described (40). The enriched B cells (5 x 104/well) were incubated with 50 mug/ml F(ab')2 goat anti-IgM (Jackson ImmunoResearch Laboratories) or LPS (5 mug/ml, Invivogen) for 48 h, as previously described (34). After pulsing with 1 muCi of [3H] thymidine for 18 h, uptake was assessed by scintillation counting.
###end p 61
###begin title 62
Analysis of SHM.
###end title 62
###begin p 63
###xml 52 54 52 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 99 100 99 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 306 309 294 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq</italic>
SHM analysis was performed as previously described (39). Genomic DNA was prepared from purified IgM+ B cells using a DNeasy Tissue kit (QIAGEN) and amplified using a Vkappa4 light chain primer set (Vkappa4-68F: 5'-GATTTTCAGCTTCCTGCTAATGAGTGCC-3' and Jkappa5int3-R; 5'-TGATAATGAGCCCTCTCCAT-3') and Platinum Taq DNA polymerase High Fidelity (Invitrogen). Amplified products were cloned into pCR2.1-TOPO vector (Invitrogen) and subjected to DNA sequence analysis.
###end p 63
###begin title 64
Quantitative real-time PCR.
###end title 64
###begin p 65
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
After RNA purification from the purified B cells using QIAshredder and RNeasy Mini kit (QIAGEN), the first strand of the cDNA was synthesized by SuperScript (Invitrogen) according to the manufacturer's instruction. Real-time PCR was performed as previously described (33). cDNA was initially amplified by using SYBR green PCR core reagent kit (Stratagene) with a primer set specific for beta-actin. The real-time PCR reaction was performed by MX3000p QPCR machine (Stratagene), and the cDNA concentration was normalized as the CT value of beta-actin. The normalized cDNA samples were subsequently subjected to real-time PCR with Rox dye as a reference dye for the measurement of expression levels of specific molecules.
###end p 65
###begin title 66
BCR repertoire.
###end title 66
###begin p 67
###xml 108 109 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 158 160 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib68">68</xref>
For DNA sequence of CDR3 within IgM heavy chain, cDNA from purified B cells were amplified using VHJ558 or VHQ52 and Cmu primer set, as previously described (68). The amplified products were cloned using TOPO-TA cloning system. Positive clones that were randomly picked up were subjected to DNA sequence.
###end p 67
###begin title 68
Detection of NF-kappaB2.
###end title 68
###begin p 69
###xml 119 120 119 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 133 134 133 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 377 379 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">55</xref>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 238 244 <span type="species:ncbi:9986">rabbit</span>
###xml 313 319 <span type="species:ncbi:9986">rabbit</span>
After B cells were positively purified from spleen and colon of pooled mice (4-30 mice) under MACS system, purified IgM+ cell (2 x 106) B cells were immediately lysed with RIPA buffer. 3.5 mug of protein was subjected to immunoblot using rabbit polyclonal anti-p52 (k-27; Santa Cruz Biotechnology, Inc.) and anti-rabbit HRP (Thermo Fisher Scientific), as previously described (55).
###end p 69
###begin title 70
Online supplemental material.
###end title 70
###begin p 71
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 114 115 114 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 125 126 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 129 130 129 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Fig. S1 shows the expression of B1 cell markers on colonic IgM+ B cells. Fig. S2 shows the BrdU-incorporated AA4.1+ and AA4.1-IgM+ cells under inflammatory condition. Fig. S3 shows BCR repertoire (VHJ558) of colonic B cells in steady state and under inflammatory condition. Fig. S4 shows the BCR repertoire (VHQ52) of colonic B cells in steady state and under inflammatory condition. The online version of this article is available at .
###end p 71
###begin title 72
Supplementary Material
###end title 72
###begin title 73
[Supplemental Material Index]
###end title 73
###begin p 74
We thank Drs. Deanna Nguyen, Katsunori Shirane, and Kiyotaka Nagahama for helpful discussion, and Ms. Ichiko Kata for technical assistance.
###end p 74
###begin p 75
This study was supported mainly by National Institutes of Health grant DK64351 (A. Mizoguchi) and partially by the Eli and Edythe L. Broad Foundation (A. Mizoguchi), DK47677 (A.K. Bhan), and DK64289 (E. Mizoguchi) and Center for the Study of Inflammatory Bowel Disease at Massachussetts General Hospital.
###end p 75
###begin p 76
The authors have no conflicting financial interests.
###end p 76

